Evaluation of the genetic variants of kinesin motor protein in ischemic stroke

J Stroke Cerebrovasc Dis. 2009 Sep-Oct;18(5):360-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.004.

Abstract

Background: The kinesin light-chain 1 genetic variants G56836C, A185C, and C406T were earlier found to amplify the development of leukoaraiosis in hypertensive smokers. These 3 variants were presumed to affect the function of the mitochondria, thereby giving rise to sensitivity to a chronic ischemic state. We have now extended our investigations to examine how the above genetic variants affect the occurrence of ischemic stroke.

Methods: Genetic and clinical data on 650 ischemic stroke and 340 neuroimaging alteration-free subjects were analyzed. Univariate and logistic regression approaches were used.

Results: None of the above genetic variants proved to be risk factors of ischemic stroke, either alone or in combination with other clinical factors.

Conclusion: The examined 3 genetic variants seem to influence the responses of the glial cells to a slight chronic hypoxia state, rather than the mechanisms resulting in cerebral infarcts themselves.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain / metabolism
  • Brain / physiopathology
  • DNA Mutational Analysis
  • Female
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics
  • Genetic Testing
  • Genetic Variation / genetics*
  • Humans
  • Hypoxia-Ischemia, Brain / epidemiology
  • Hypoxia-Ischemia, Brain / genetics*
  • Hypoxia-Ischemia, Brain / physiopathology
  • Kinesins / genetics*
  • Male
  • Middle Aged
  • Neuroglia / metabolism
  • Oxygen Consumption / physiology
  • Polymorphism, Genetic / genetics
  • Risk Factors
  • Stroke / epidemiology
  • Stroke / genetics*
  • Stroke / physiopathology

Substances

  • Genetic Markers
  • Kinesins